DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,596,000 | -71.2% | 368,042 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $12,506,000 | -9.6% | 368,042 | -2.6% | 0.00% | 0.0% |
| Q2 2021 | $13,834,000 | -5.0% | 377,879 | +16.3% | 0.00% | 0.0% |
| Q1 2021 | $14,567,000 | -41.2% | 324,868 | -25.1% | 0.00% | -50.0% |
| Q4 2020 | $24,762,000 | +8.5% | 433,882 | -2.5% | 0.01% | 0.0% |
| Q3 2020 | $22,821,000 | -1.5% | 444,860 | +14.6% | 0.01% | -14.3% |
| Q2 2020 | $23,176,000 | +213.9% | 388,079 | +116.4% | 0.01% | +133.3% |
| Q1 2020 | $7,384,000 | +5.9% | 179,355 | -46.0% | 0.00% | 0.0% |
| Q4 2018 | $6,974,000 | -64.0% | 332,261 | -33.5% | 0.00% | -50.0% |
| Q3 2018 | $19,360,000 | -1.6% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $19,675,000 | +1209.0% | 500,000 | +566.7% | 0.01% | +600.0% |
| Q1 2018 | $1,503,000 | -11.6% | 75,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,700,000 | +19.4% | 75,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,424,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |